CANDEL THERAPEUTICS INC. - COMMON STOCK
6.6500
04-October-24 15:59:57
15 minutes delayed
Stocks
-0.0600
-0.89%
Today's range
6.4600 - 6.8800
ISIN
N/A
Source
NASDAQ
-
06 Dec 2022 16:26:35 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Host Virtual R&D Day on December 6, 2022
29 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10 Nov 2022 08:00:03 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Clinical Data Presentations at SITC and SNO
07 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation for November
01 Nov 2022 08:00:03 By Nasdaq GlobeNewswire
-
15 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Two Executive Leadership Appointments
07 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation
06 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
05 Aug 2022 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
18 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
12 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
27 Apr 2022 16:00:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
02 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
01 Mar 2022 08:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Appoints Dr. Francesca Barone as Chief Scientific Officer
03 Feb 2022 08:00:01 By Nasdaq GlobeNewswire